INS and pneumonia: Contrary to the association of insulin and pneumonia risk, Yang et al. demonstrated in a retrospective cohort study of 22,638 patients with type 2 diabetes mellitus that patients who had at least 90 days’ stable metformin therapy have a reduced risk of pneumonia [29].